Unlocking chemical matter on scale

webinar

Tue, 07 Jul 2020, 17:00 CEST (Berlin)

Dr. Serghei Glinca, CEO Crystals First GmbH, Marburg, Germany

Unlocking chemical matter on scale

Fragment-based lead discovery (FBLD) has undoubtedly become an invaluable resource for medicinal chemists in the identification of lead candidates.

Since an efficient fragment evolution requires structural data of protein-ligand interactions, a variety of biophysical methods are applied in a cascade approach as a set of prefilter prior to structure determination. Systematic studies suggest that the cascade approach significantly reduces the hit rate compared to a direct crystallographic screening.

The application of X-ray crystallography as a primary fragment screening method has been underutilized due to the limited availability of a robust system for soaking experiments and solubility issues of fragments. One of major bottlenecks in the experimental setup for crystal soaking is the sensitivity of protein crystals. We overcome this limitation using the SmartSoak® technology, which stabilizes protein crystals leading to high-performance soaking systems. No trial-and-error optimization of the soaking system needed.

In case studies, we demonstrate the advantages of the application of crystallographic fragment screening as a primary screening strategy for the hit identification. The resulting structural data can now be utilized to explore the chemical space on scale using computational methods.

Current news

category
Events
BioSolveIT at 34th GP2A 2026 Conference on Medicinal Chemistry in Gothenburg
December 17, 2025 15:19 CET
BioSolveIT is honored and excited to participate in the 34th GP2A 2026 Conference on Medicinal Chemistry in Gothenburg. From August 26 to 28, 2026, the Group for the Promotion of Pharmaceutical Chemistry in Academia (GP2A), a member-led network of academic medicinal chemists working at universities and research institutes in Europe,...
Read on
BioSolveIT wrapped 2025
December 15, 2025 06:18 CET
Our Year in Drug Discovery In 2025, we focused on bridging the gap between computational prediction and compound tangibility. Along the way we refined and evolved our platforms to ensure that drug discovery is not only faster, but also more accessible and reliable for researchers everywhere. This year saw the...
Read on
category
Challenge
Emina Yekt Yilmaz Wins Scientific Challenge Winter 2024!
December 9, 2025 14:52 CET
It is our greatest pleasure to announce the winner of the Winter 2024 edition of the Scientific Challenge: the winner is Emine Yekta Yilmaz from Haceteppe and Gazi Universities (Ankara, Turkey) with her project ‘Leveraging AI and Physics-Based Screening for the Identification of sEH Inhibitors’. Based on standardized compound datasets...
Read on